共 211 条
[1]
Ghoncheh M(2016)Incidence and mortality and epidemiology of breast cancer in the world Asian Pac J Cancer Prev 17 43-46
[2]
Pournamdar Z(2016)Clinical relevance of host immunity in breast cancer: from TILs to the clinic Nat Rev Clin Oncol 13 228-241
[3]
Salehiniya H(2014)Tumor-infiltrating lymphocytes are prognostic in triple negative breast cancer and predictive for trastuzumab benefit in early breast cancer: results from the FinHER trial Ann Oncol 25 1544-1550
[4]
Savas P(2018)Tumour-infiltrating lymphocytes and prognosis in different subtypes of breast cancer: a pooled analysis of 3771 patients treated with neoadjuvant therapy Lancet Oncol 19 40-50
[5]
Salgado R(2016)Clinical significance of tumor-infiltrating lymphocytes in breast cancer J Immunother Cancer 4 59-251
[6]
Denkert C(2017)Assessing tumor-infiltrating lymphocytes in solid tumors: a practical review for pathologists and proposal for a standardized method from the International Immunooncology Biomarkers Working Group: Part 1: assessing the host immune response, tils in invasive breast carcinoma and ductal carcinoma in situ, metastatic tumor deposits and areas for further research Adv Anat Pathol 24 235-787
[7]
Sotiriou C(2008)Reguratory T cell and immune tolerance Cell 133 775-500
[8]
Darcy PK(2010)FOXP3+ regulatory T cell in the human immune system Nat Rev Immunol 10 490-7
[9]
Smyth MJ(2010)Regulatory T cells in cancer immunotherapy Curr Opin Immunol 27 1-278
[10]
Loi S(2009)A low number of tumor-infiltrating FOXP3-positive cells during primary systemic chemotherapy correlates with favorable anti-tumor response in patients with breast cancer Oncol Rep 22 273-1280